Landos Biopharmaincis A Clinical Stage Biopharmaceutical Company Based In Blacksburgvirginiait Specializes In Developing First In Class Oral Therapeutics For Autoimmune Diseasesfollowing Its Acquisition By Abbvie Incin May 2024Landos Focuses On Addressing Unmet Needs In Inflammatory And Autoimmune Conditions Through Immunometabolic Modulation Pathways Founded In 2017Landos Has A Pipeline Of Novel Small Molecule Therapies Targeting Immune Pathwayskey Products Include Nx 13Which Is In Phase 2 Trials For Ulcerative Colitis And Has Completed Phase 1 For Crohnae S Diseaseother Therapies In Development Target Conditions Such As Asthmamultiple Sclerosisand Rheumatoid Arthritisthe Company Emphasizes Safermore Effective Oral Treatments As Alternatives To Injectable Biologicsaiming To Improve Patient Outcomes In Autoimmune Disease Management
No conferences found for this company.
| Company Name | Landos Biopharma Inc |
| Country |
United States
|
| Address | 1800 Kraft Drivesuite 216blacksburg Va 24060united States |
| Telephone | Login to View |
| Login to View |
